Recent studies have demonstrated that the naturally occurring perylenequino
ne antibiotic calphostin C is a potent inhibitor of protein kinase C and ca
n induce apoptosis in some tumor cell lines by an as yet unknown mechanism,
Here we demonstrate that calphostin C induces dose-dependent apoptosis in
DT40 chicken lymphoma B-cells, and targeted disruption of lyn, syk, btk, PL
C gamma 2, or IP3R genes does not prevent or attenuate its cytotoxicity. In
our study, calphostin C also induced rapid apoptosis in human acute lympho
blastic leukemia (ALL) cell lines ALL-1 (BCR-ABL(+) pre-pre-B ALL), RS4;11
(MLL-AF4(+) pro-B ALL), NALM-6 (pre-B ALL), DAUDI (Burkitt's/B-cell ALL), M
OLT-3 (T-ALL), and JURKAT (T-ALL), whereas other potent PKC inhibitors did
not. In biochemical studies, calphostin C was discovered to induce rapid ca
lcium mobilization from intracellular stores of ALL cell lines, and its cyt
otoxicity against ALL cell lines was well correlated with the magnitude of
this calcium signal. Calphostin C-induced apoptosis,vas markedly suppressed
by BAPTA/AM, a cell-permeable Ca2+ chelator as well as NiCl2, an inhibitor
of Ca2+/Mg2+-dependent endonucleases. Inhibition of the Ca2+/calmodulin-de
pendent phosphatase calcineurin dth perfluoreperazine dimadeate (a calmodul
in antagonist) or cyclosporin A (a specific inhibitor of calcineurin) also
reduced the magnitude of calphostin C-induced apoptosis in ALL cell lines.
Calphostin C was capable of inducing calcium mobilization and apoptosis in
freshly obtained primary leukemic cells from children with ALL. Taken toget
her, our results provide unprecedented evidence that calphostin C triggers
a Ca2+-dependent apoptotic signal in human ALL cells.